The Pellecome™ Vision
Pellecome LLC is the vision of Dr. Enrique G. Jacome, a board-certified Ob-Gyn who was certain there was a better way to provide hormone balance to patients than the methods that were available. His objective was to develop an improved, simplified method of administration and better quality hormone pellets. He also believed that streamlining the therapeutic process would allow healthcare professionals with various levels of experience to incorporate Bio-identical Hormone Replacement Therapy (BHRT) into their practices.
The vision was based on many years of experience. Dr. Jacome has been a specialist in hormone replacement therapy since 1995. In 2002, he turned his focus to natural hormone replacement therapy, using timed-release BHRT pellet implants. Compounded using hormones biologically identical to those created naturally in the body, fused pellet implants are the size of a grain of rice and are inserted under the skin in a simple office procedure.
Today, Dr. Jacome is recognized as a leader in the field of hormone balance, with considerable experience in providing bio-identical hormone pellets safely. The approach he developed is clinically sound and capable of providing the optimal delivery of hormones to both men and women who suffer from hormone imbalance.
Dr. Jacome’s depth of knowledge is not only derived from having his own clinic dedicated to hormone replacement therapy, but also from the inestimable experience that comes from using the pellets himself. He has placed more than 30,000 implants over the last two decades.
The Pellecome Team™
Enrique G. Jacome, MD, Founder
Board certified by the American College of Obstetrics and Gynecology, Dr. Enrique G. Jacome completed his residency at Harbor-UCLA Medical Center. Dr. Jacome has been a practicing gynecologist with Eisenhower Medical Center since 1995 and is a leading expert in Robotic Surgery, having performed close to 1,000 robotic procedures and more than 3,000 laparoscopic cases. His work has been published in the Journal of Robotic Surgery, Journal of Minimally Invasive Gynecology, and the Journal of Reproductive Medicine. He has presented at many major national and international conferences, including the World Congress of Gynecologic Endoscopy, as well as the Annual Meeting of the American Association of Gynecologic Laparoscopists.
In 2008, Dr. Jacome was the first physician in Riverside County, California, to perform robotic surgery using the da Vinci® S HD Surgical System. In 2010, the Auxiliary at Eisenhower Medical Center honored Dr. Jacome with the “Distinguished Service Award for Outstanding Patient Care.” He received the 2011 Physician of the Year Award at Eisenhower Medical Center and in 2012 Physician of the Year for the Hispanic Community.
In 2012, the International Association of Obstetricians and Gynecologists recognized Dr. Jacome as a Leading Physician of the World and Top Obstetrician and Gynecologist in California. Other awards include 2012 Southern California Top Doctor Obstetrician and Gynecologist, 2011 and 2012 Palm Springs Life Top Doctor in Obstetrics and Gynecology, 2013 Los Angeles and San Diego Top Doctor in Obstetrics and Gynecology. From 2011 to 2017, Dr. Jacome was selected by his peers as a Top Doctor in Obstetrics and Gynecology.
As a pioneer and innovator with a unique background in minimally invasive surgery and hormone pellet insertion therapy, Dr. Jacome is committed to improving the insertion technique and the pharmacokinetics related to the pellet manufacturing process.
Melissa Vinci-Rainis, CEO
Melissa brings a proven track record as an expert in the healthcare industry with over 20 years of experience. Her comprehensive knowledge of medical devices and women’s healthcare was the result of her work in the pharmaceutical industry where she managed new business development, marketing and sales operations, and licensing and acquisitions for Ortho-McNeil, Ethicon, and Johnson & Johnson. Most recently, Melissa was the COO and Vice President of Bergen Medical Products, a medical device start-up. She helped bring a combination of innovation, experience, and science to deliver high quality, cost effective products.
As CEO, Melissa will direct all operations within Pellecome, including research, product development and approval.
Amy Billups Batra, VP Sales and Marketing
Through 20 years working in start-up companies and large pharmaceuticals, Amy has sustained a track record of top performance in sales, training, marketing and management.
Amy has worked for Bausch & Lomb, Sanofi Aventis, Merz, Johnson & Johnson, Kantar Health and Factor Medical; partnering with a wide range of stakeholders such as medical societies, key opinion leaders, medical trainers and global partners. Amy has also acquired expertise in aesthetics, dermatology and regenerative medicine; developed new products and created a highly successful model for physician training under Continuing Medical Education (CME).
As Vice President of Sales and Marketing, Amy will help drive Pellecome’s new products in 2018 and beyond.
Pellecome™ Value Proposition
Pellecome is setting the standard in Bio-identical Hormone Replacement Therapy (BHRT) by providing solutions to Healthcare Providers.
In mid-2018, Pellecome is launching the Re3™ Advanced Pellet Delivery System for Men and Women, which enables clinicians to insert hormone pellets easily and safely using patent pending technology.
Later in 2018, Pellecome will launch the Re3™ Advanced Pellet Formulations. Partnering with an established specialty pharmaceutical company, Pellecome has created pellet formulations that are designed to provide patients consistent and controlled hormone absorption. Pellecome Re3™ Advanced Pellet Formulations are manufactured in compliance with FDA requirements for potency, quality, and sterility according to regulations established for 503B Outsourcing Facilities to help ensure the safety and efficacy of hormone pellets. Our goal at Pellecome is to provide a safe and predictable method based on controlled-release technologies supported by clinical evidence.
We are committed to providing physicians with training that is focused on achieving the optimal insertion technique with a minimal risk profile. These courses are offered frequently and in several geographical locations for your convenience.
Pellecome LLC is headquartered in Randolph, New Jersey, with manufacturing sites in multiple locations.
The Pellecome Membership will be announced later in 2018.